deferiprone has been researched along with Ambulation Disorders, Neurologic in 2 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty Friedreich's ataxia patients were treated with idebenone (20 mg/kg/day) and deferiprone (20 mg/kg/day) for 11 months." | 1.37 | Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. ( Aracil, A; Artuch, R; Blanch, J; Capdevila, A; Jiménez, L; Mas, A; Montero, R; O'Callaghan, M; Pineda, M; Tondo, M; Velasco-Sánchez, D, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carboni, E | 1 |
| Tatenhorst, L | 1 |
| Tönges, L | 1 |
| Barski, E | 1 |
| Dambeck, V | 1 |
| Bähr, M | 1 |
| Lingor, P | 1 |
| Velasco-Sánchez, D | 1 |
| Aracil, A | 1 |
| Montero, R | 1 |
| Mas, A | 1 |
| Jiménez, L | 1 |
| O'Callaghan, M | 1 |
| Tondo, M | 1 |
| Capdevila, A | 1 |
| Blanch, J | 1 |
| Artuch, R | 1 |
| Pineda, M | 1 |
2 other studies available for deferiprone and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation.
Topics: alpha-Synuclein; Animals; Cell Count; Deferiprone; Drug Evaluation, Preclinical; Female; Gait Disord | 2017 |
Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
Topics: Adolescent; Adult; Antioxidants; Blood Cell Count; Brain Chemistry; Child; Deferiprone; Drug Therapy | 2011 |